Project Grant K23DA061256
Award Date
8/1/25
Completion Date
7/31/30
Dollars Obligated
$194K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
New York, USA
Similar Awards
This $194,098 Project Grant award under the National Institute on Drug Abuse's (NIDA) Drug Use and Addiction Research Programs (CFDA 93.279) is designed to provide the principal investigator, Dr. Erath, with mentored training in implementation science to become an independent investigator focused on advancing the implementation of evidence-based treatments for stimulant use disorder and other substance use disorders in harm reduction and community treatment settings. The key objectives of the...
This Project Grant award of $769,708 was provided by the National Institute on Drug Abuse (NIDA) under the federal Drug Use and Addiction Research Programs (CFDA 93.279). The award supports research to assess self-efficacy, perceived peer and familial norms, and motivation to reduce alcohol and/or cannabis use and engage in treatment referral among assault-injured emerging adults. The research aims to adapt and pilot test a Brief Negotiation Interview (BNI) intervention for use in the...
This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $208,575 to The McLean Hospital Corporation to expand mentorship of early-career investigators in patient-oriented research on substance use disorders. The award will enable the principal investigator, Dr. R. Kathryn McHugh, to dedicate more time to mentoring current and new mentees, as well as expand her own program of patient-oriented research. Key...
The National Institute on Drug Abuse (NIDA) awarded a $264,000 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Innovation Research And Training, Inc. (IRT), a woman-owned small business research organization based in Durham, North Carolina. The purpose of this 3-year project, beginning September 2024, is to evaluate the "Substance of Change: Building Assets in Mentees Affected by Substance Misuse" (SOC), an interactive, multimedia, web-based,...
The National Institute on Drug Abuse (NIDA) awarded a $306,528 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Addinex Technologies, Inc. The grant will fund the development of a medication adherence and monitoring system to support decentralized clinical trials for substance use disorder (SUD). The project aims to adapt Addinex's existing medication management system to provide researchers running SUD clinical trials with a tool for at-home dispensing that...
This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $844,475 to the University of Alabama at Birmingham (UAB) to test a bundled intervention aimed at increasing treatment uptake for patients with opioid use disorder (OUD) and nonfatal opioid overdoses after emergency department (ED) discharge. The proposed intervention combines telehealth, peer support, buprenorphine prescribing, and linkage to...
This federal Project Grant award, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), supports the development of an undergraduate research program at Rutgers, The State University of New Jersey. The $524,272 award aims to promote the advancement of students from underrepresented groups in the field of addiction research through the "Training in Research Undergraduate Experience through the Rutgers Addiction Research...
This $1,078,339 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports the "PREPARING INDIGENOUS SCIENTISTS TO LEAD INNOVATIVE SUBSTANCE USE RESEARCH: THE NATIVE CHILDREN'S RESEARCH EXCHANGE SCHOLARS PROGRAM". The grant aims to foster the development of early career Indigenous substance use and disorder researchers, particularly those focused on the impacts and developmental course of problematic...
This federal Project Grant award of $157,684, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), will fund a study to understand inequities in harm reduction services (HRS) provided to persons with opioid use disorder in hospital settings. The study will use natural language processing (NLP) and electronic health record (EHR) data to characterize providers' recommendations of psychosocial/environmental and...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under CFDA 93.279 Drug Use and Addiction Research Programs, provides $3,503,736 to Seattle Children's Hospital (doing business as Seattle Children's Research Institute) to develop and test a multilevel substance use disorder (SUD) and overdose prevention strategy for rural youth involved in county juvenile court systems. The project aims to collaboratively co-design the prevention strategy and an implementation...